In 2023, imports of streptomycins to China were lower compared to future forecasts, marking a significant upward trajectory in the coming years. From 2024 to 2028, forecasts indicate a consistent increase in import volumes, with a year-on-year growth rate averaging around 5%. The steady rise suggests strong, sustained demand.

Key trends to watch include:

Potential changes in China's domestic production capabilities.
Alterations in international trade agreements or tariffs that could impact import flow.
The development of alternative antibiotics that may compete with streptomycin imports.